Edition: International | Greek
MENU

Home » Europe

Health Union: a stronger role for the European Medicines Agency

The EU will be better prepared to manage future health crises by tackling shortages of medicines and medical devices more effectively

By: EBR - Posted: Thursday, January 20, 2022

"New EU platform to monitor and report medicine shortages".
"New EU platform to monitor and report medicine shortages".

The EU will be better prepared to manage future health crises by tackling shortages of medicines and medical devices more effectively.

Parliament endorsed the provisional agreement reached with the Council last year on increasing the powers of the EU’s medicines regulator with 655 votes in favour, 31 against and 8 abstentions.

The European Medicines Agency (EMA) will be better equipped to monitor and mitigate shortages of medicinal products and medical devices considered to be critical in order to address public health emergencies. Two “shortages steering groups”, for medicines and medical devices respectively, will be created and the EMA will set up and manage the European Shortages Monitoring Platform to facilitate data collection.

All actors in the supply chain will be involved more closely, including expert advice from observers representing patients and medical professionals, as well as marketing authorisation holders, wholesale distributors or any other relevant healthcare stakeholders.

The agency will also set up a public webpage with information on shortages. Data related to clinical trials and product information on authorised medicinal products will be made available more timely and transparently.

Quote

Rapporteur Nicolas Gonzalez Casares (S&D, ES) said: “The new regulation makes both the Agency and all actors in the supply chain more transparent, involving them more in the process and fostering synergies between EU agencies. Moreover, we pave the way to promoting clinical trials for the development of vaccines and treatments, boosting transparency on those issues. And, with the new European Shortages Monitoring Platform, we provide the Agency with a key tool to monitor medicines supply and prevent shortages. In short, more transparency, more participation, more coordination, more effective monitoring and more prevention.”

Next steps

Following the final vote in plenary, the text will be published in the EU Official Journal shortly after. The regulation will apply as of 1 March 2022.

Background

As part of building a European Health Union, the Commission proposed on 11 November 2020 a new health security framework fit for future health challenges, based on lessons learnt from combatting COVID-19, which includes a proposal to increase the powers of the European Medicines Agency.

*Source: European Parliament

READ ALSO

EU Actually

Moving towards an ever-closer European Union?

N. Peter KramerBy: N. Peter Kramer

The ‘Conference on the Future of Europe (please read: European Union!)’ has had his closing event. The purpose of the Conference was to engage citizens in a broad debate on the future of the EU

View 04/2021 2021 Digital edition

Magazine

Current Issue

04/2021 2021

View past issues
Subscribe
Advertise
Digital edition

Europe

EU study: CAP support for ‘couch’ farmers negatively impacts farm communities

EU study: CAP support for ‘couch’ farmers negatively impacts farm communities

Common Agricultural Policy support for landowners not actively engaged in farming has indirectly negatively impacted farming communities, at the same time as the EU continues to haemorrhage farms at an alarming rate, a new EU study has found

Business

How digitalization of industries can empower humanity

How digitalization of industries can empower humanity

5G can play a pivotal role in transforming industries to be more flexible, productive and sustainable

MARKET INDICES

Powered by Investing.com
All contents © Copyright EMG Strategic Consulting Ltd. 1997-2022. All Rights Reserved   |   Home Page  |   Disclaimer  |   Website by Theratron